×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Lobe Sciences Ltd. and Clearway Global Announce Change of Control and Focus on Creating Value for Shareholders
Business Wire
VANCOUVER, British Columbia--(BUSINESS WIRE)--Lobe Sciences Ltd. (“Lobe” or the “Company”) (OTCQB: LOBEF) (CSE: LOBE), a biopharmaceutical...
1 week ago
Lobe Sciences Announces Strategic Control Shift - TipRanks.com
Tipranks
Lobe Sciences (TSE:LOBE) has released an update. Lobe Sciences Ltd., a biopharmaceutical company, has announced a change of control after...
6 days ago
Pα+ Psychedelic Patent Analysis: A Mebufotenin Melee (Dec '23 & Jan '24)
Psychedelic Alpha
This month: We Explore IP and Exclusivity in 5-MeO-DMT Drug Development Across GH Research and Beckley Psytech • Browse the Interactive...
3 months ago
Lobe Sciences Provides Company Review of 2023
Business Wire
Lobe Sciences is a biopharmaceutical company focused on developing transformative medicines to treat rare diseases. The Company, through...
4 months ago
Lobe Sciences announces change of control | CSE:LOBE, OTCQB:LOBEF
Proactive Investors
Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBEF) has announced a change in voting control of the company and enhancements to its growth strategy.
1 week ago
Canadian biotech Lobe Sciences taps Australian CRO iNGENū for psychedelic drug trial
Fierce Biotech
Lobe Sciences is hiring the Australia-based CRO iNGENū to carry out at least three trials for the Canadian biotech's psychedelic drug...
21 months ago
SCD treatment Altemia to get US distribution in new agreement |...
Sickle Cell Disease News
Lobe Sciences partnered with Pentec Health to distribute Altemia, a DHA formulation for sickle cell disease, in the U.S. and its...
12 months ago
Trip to Treatment: Lobe Sciences CEO Touts Targeted Low Dosing for Better Patient Outcomes.
Investing News Network
Low dosing that targets the right receptor could yield better treatment results and build the foundation for a global psychedelics...
19 months ago
Protracted neuronal recruitment in the temporal lobes of young children
Nature
The temporal lobe of the human brain contains the entorhinal cortex (EC). This region of the brain is a highly interconnected integrative...
5 months ago
Lobe Sciences, Ltd. Announces the Acquisition of Altemia(TM) & Company
Yahoo Finance
Move Affirms Lobe's Position as an Orphan/Rare Disease Drug Development Company and expands portfolio to include 4 Orphan Disease Programs...
13 months ago